Literature DB >> 1097472

A study of immunoglobulin M antibody to measles, canine distemper, and rinderpest viruses in sera of patients with subacute sclerosing panencephalitis.

D Thomson, J H Connolly, B O Underwood, F Brown.   

Abstract

Seven boys were studied who had the clinical features of subacute sclerosing panencephalitis (SSPE) and whose brain histology was consistent with SSPE. Measles antigen was detected in the seven brains by the direct fluorescent antibody method. Three out of the seven boys had in their sera measles specific immunoglobulin M (IgM) which was detected by the indirect fluorescent antibody method, and the cell receptors for it were acetone stable. A prozone effect was noted in the sera of two patients. The absorption of one patient's serum with Staphylococcus aureus to reduce the titre of immunoglobulin G (IgG) removed the prozone effect. Two of the boys who had high titres of measles specific IgM also had serum IgM which reacted with canine distemper virus antigen but the titres were eightfold lower. None of the boys had detectable rinderpest specific IgM in their sera.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1097472      PMCID: PMC475767          DOI: 10.1136/jcp.28.7.543

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

1.  Diagnosis of recent Herpes simplex infections. A modified immunofluorescent test for the detection of specific Herpes simplex IgM antibodies after staphylococcal adsorption of IgG.

Authors:  K Skaug; E Tjotta
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-06

2.  Determination of different cytomegalovirus immunoglobulins (IgG, IgA, IgM) by immunofluorescence.

Authors:  H Schmitz; R Haas
Journal:  Arch Gesamte Virusforsch       Date:  1972

3.  Measles-virus antibody and antigen in subacute sclerosing panencephalitis.

Authors:  J H Connolly; I V Allen; L J Hurwitz; J H Millar
Journal:  Lancet       Date:  1967-03-11       Impact factor: 79.321

4.  Letter: Multiple sclerosis and virus antigens.

Authors:  K B Fraser; M Haire; P V Shirodaria; J H Millar
Journal:  Lancet       Date:  1973-12-01       Impact factor: 79.321

5.  Epstein-Barr virus-specific IgM in infectious mononucleosis, Burkitt lymphoma, nasopharyngeal carcinoma.

Authors:  J E Banatvala; J M Best; D K Waller
Journal:  Lancet       Date:  1972-06-03       Impact factor: 79.321

6.  Subacute sclerosing panencephalitis. Clinical, pathological, epidemiological, and virological findings in three patients.

Authors:  J H Connolly; I V Allen; L J Hurwitz; J H Millar
Journal:  Q J Med       Date:  1968-10

7.  Specific IgG and IgM antibody responses in herpes-simplex-virus infections.

Authors:  J B Kurtz
Journal:  J Med Microbiol       Date:  1974-08       Impact factor: 2.472

8.  Inhibition of antichlamydial IgM antibody by IgG antibody in immunofluorescence tests.

Authors:  S V Juchau; W D Linscott; J Schachter; E Jawetz
Journal:  J Immunol       Date:  1972-06       Impact factor: 5.422

9.  IgG, IgA and IgM responses in acute rubella determined by the immunofluorescent technique.

Authors:  J E Cradock-Watson; M S Bourne; E M Vandervelde
Journal:  J Hyg (Lond)       Date:  1972-09

10.  Measles immunoglobulins in subacute sclerosing panencephalitis.

Authors:  J H Connolly; M Haire; D S Hadden
Journal:  Br Med J       Date:  1971-01-02
View more
  3 in total

1.  Nosocomial rotavirus gastroenteritis in a neonatal nursery.

Authors:  J F Glasgow; B G McClure; J H Connolly; H J O'Neill
Journal:  Ulster Med J       Date:  1978

2.  Humoral immunity in leprosy: immunoglobulin G and M antibody responses to Mycobacterium leprae in relation to various disease patterns.

Authors:  J Touw; E M Langendijk; G L Stoner; A Belehu
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

3.  Low molecular weight measles immunoglobulin M in subacute sclerosing panencephalitis and acute measles.

Authors:  J H Connolly; D M Simpson; A Trudgett; A P Hopkins
Journal:  Postgrad Med J       Date:  1985-05       Impact factor: 2.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.